Drugs / Vi-rEPA
last change Jan 2011 re-read 3 minutes ago

Vi-rEPA

Vaccine

Developed for
typhoid fever
Investigated by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00342628 Jul 2006 → Apr 2008 typhoid fever Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vi-rEPA ClinicalTrials.gov intervention name — accepted as the source's own label NCT00342628 ↗
Modality Vaccine “Vi-rEPA conjugate vaccine for typhoid fever” NCT00342628 ↗